Arovid Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.00 M
as on 15-12-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -15.28%
(FY 2020)
- Profit -55.07%
(FY 2020)
- Ebitda 22.06%
(FY 2020)
- Net Worth 0.17%
(FY 2020)
- Total Assets -3.03%
(FY 2020)
About Arovid Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Idhaya Chandran and Sridhar Manavalan serve as directors at the Company.
- CIN/LLPIN
U24100UP2018PTC105661
- Company No.
105661
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2018
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arovid Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Idhaya Chandran  | Director | 06-Jul-2018 | Current |
| Sridhar Manavalan | Director | 13-Jul-2018 | Current |
Financial Performance of Arovid Pharmaceuticals.
Arovid Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 15.28% decrease. The company also saw a substantial fall in profitability, with a 55.07% decrease in profit. The company's net worth moved up by a moderate rise of 0.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arovid Pharmaceuticals?
Unlock access to Arovid Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Turbotech Projects And Services Private LimitedActive 8 years 3 monthsIdhaya Chandran and Sridhar Manavalan are mutual person
Brizza Chem Private LimitedActive 5 years 9 monthsIdhaya Chandran and Sridhar Manavalan are mutual person
- Turbotech Engineers & Infrastructures Private LimitedActive 5 years 14 days
Idhaya Chandran and Sridhar Manavalan are mutual person
- Aerogreen Services Private LimitedActive 4 years 4 months
Idhaya Chandran and Sridhar Manavalan are mutual person
- Imperial Sugar & Ethanol Technologies (International) Private LimitedActive 7 years 1 month
Sridhar Manavalan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arovid Pharmaceuticals?
Unlock and access historical data on people associated with Arovid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arovid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arovid Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
